BRAVE news: another one bites the dust

Nature Reviews Rheumatology, Published online: 03 April 2023; doi:10.1038/s41584-023-00957-xThe results of the two BRAVE phase III trials of baricitinib in the treatment of systemic lupus erythematosus were inconclusive, meaning that this clinical trial programme has now been terminated.
Source: Nature Reviews Rheumatology - Category: Rheumatology Authors: Source Type: research